olimel n12e
baxter medical ab - alanin / arginin / aspartinsyre / glutaminsyre / glysin / histidin / isoleucin / leucin / lysinacetat / metionin / fenylalanin / prolin / serin / treonin / tryptofan / tyrosin / valin / natriumacetattrihydrat / natriumglyserofosfat, hydrert / kaliumklorid / magnesiumkloridheksahydrat / glukosemonohydrat / kalsiumkloriddihydrat / soyaolje, renset / olivenolje, renset - infusjonsvæske, emulsjon
pemetrexed krka
krka d.d. - pemetrexed disodium - carcinoma, non-small-cell lung; mesothelioma - antineoplastiske midler - ondartet pleural mesotheliomapemetrexed krka i kombinasjon med cisplatin er angitt for behandling av kjemoterapi naive pasienter med inoperabel ondartet pleural mesothelioma. non-small cell lung cancerpemetrexed krka i kombinasjon med cisplatin er angitt for det første-linje behandling av pasienter med lokalt avansert eller metastatisk ikke-liten celle lunge kreft annet enn overveiende plateepitelkreft histology. pemetrexed krka er indisert som monoterapi for vedlikehold behandling av lokalt avansert eller metastatisk ikke-liten celle lunge kreft annet enn overveiende plateepitelkreft histology hos pasienter med sykdommen har ikke kommet umiddelbart etter platinum-basert kjemoterapi. pemetrexed krka er indisert som monoterapi for andre-linje behandling av pasienter med lokalt avansert eller metastatisk ikke-liten celle lunge kreft annet enn overveiende plateepitelkreft histology.
hyzaar 50 mg / 12.5 mg
orifarm as - losartankalium / hydroklortiazid - tablett, filmdrasjert - 50 mg / 12.5 mg
cozaar comp 50 mg / 12.5 mg
orifarm as - losartankalium / hydroklortiazid - tablett, filmdrasjert - 50 mg / 12.5 mg
cozaar comp forte 100 mg / 25 mg
orifarm as - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 25 mg
cozaar comp 100 mg / 12.5 mg
orifarm as - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 12.5 mg
cozaar comp 50 mg / 12.5 mg
orifarm as - losartankalium / hydroklortiazid - tablett, filmdrasjert - 50 mg / 12.5 mg
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiske midler - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
cozaar comp 100 mg / 12.5 mg
2care4 aps - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 12.5 mg
cozaar comp forte 100 mg / 25 mg
2care4 aps - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 25 mg